Release Date: 24/11/10 12:47 Summary: Ledjadja ownership increased to 74% Price Sensitive: Yes Download Document 23.86KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%